GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
59.00
-0.14 (-0.24%)
At close: May 12, 2025, 4:00 PM
61.12
+2.12 (3.59%)
After-hours: May 12, 2025, 7:53 PM EDT
GeneDx Holdings Employees
GeneDx Holdings had 1,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
1,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$330,143
Profits / Employee
-$38,576
Market Cap
1.68B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,000 | 0 | - |
Dec 31, 2023 | 1,000 | -100 | -9.09% |
Dec 31, 2022 | 1,100 | -100 | -8.33% |
Dec 31, 2021 | 1,200 | 328 | 37.61% |
Dec 31, 2020 | 872 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
WGS News
- 5 days ago - GeneDx Announces Completion of Fabric Genomics Acquisition - Business Wire
- 12 days ago - GeneDx Holdings Corp. (WGS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - GeneDx Reports First Quarter 2025 Financial Results and Business Highlights - Business Wire
- 14 days ago - GeneDx: Strengthening Leadership In Genomic Diagnostics - Seeking Alpha
- 26 days ago - GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale - Business Wire
- 4 weeks ago - GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025 - Business Wire
- 5 weeks ago - GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication - Business Wire
- 7 weeks ago - GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire